Pfizer has been dismissed as a defendant in a sweeping antitrust lawsuit in which most U.S. states accused dozens of drugmakers and executives of fixing prices of generic drugs, causing patients to overpay. In a decision on Tuesday, Chief Judge …
Nuclear Verdicts Go Boom, Increase 40.7% in 2025
So-called “nuclear” verdicts did not subside in 2025. In fact, it was quite the opposite. According to a new report from strategic communications and research